Witness the recently unpopular US Preventive Services Task Force. Nearly all the specialists were willing to brand this primary care driven group when the USPSTF came out against screening for prostate cancer. At first, the studies were considered wrong or poorly run. Then the USPSTF was wrong because there were no urologists involved in the making of the recommendations. And now, there are efforts underway to disband & disbar this group from any further interpretation of medical literature. What's really impressive & telling is the backlash as noted by Gary Schwitzer in his blog last week.
So I find it rather ironic that a study published in the New England Journal of Medicine last Thursday concluded that radical prostatectomy did not improve (reduce) all-cause, or even prostate cancer, mortality, in localized cancers, as compared to active surveillance, otherwise known as watchful waiting or observation, over a dozen years after screening. One would have expected at least some reduction in prostate cancer mortality w/radical prostatectomy; after all, you're removing a cancer, right? But this is exactly why we need science rather than assumptions.
It turns out that radical prostatectomy really offers no benefit at all, especially with regards to the gold standard, all-cause mortality, otherwise known to me as Whac-A-Mole medicine. Worse, by undergoing surgery, one risks giving up urinary continence, erectile function, and overall quality of life. Which begs the question, why screen for prostate cancer in the first place? Unless you're holding a hammer in your hand, in which case, everything tends to look like a nail. Maybe it's time to get rid of that old medical school surgery adage, a chance to cut is a chance to cure. By holding a pen, I have nothing to gain or lose when it comes to your care. Let's remember to put our patients' interests first.
Tweet
No comments:
Post a Comment